Top Markets
#1 GEKKO GEKKO +51.79%
#2 Helium Helium +43.91%
#3 Pons Pons +21.40%
#4 ADO Protocol ADO Protocol +18.01%
#5 Main Street Yield Main Street Yield +17.48%
#6 Collect on Fanable Collect on Fanable +16.09%
#7 龙虾 (Lobster) 龙虾 (Lobster) +15.52%
#8 o1.exchange o1.exchange +13.32%
#9 Velvet Velvet +12.38%
#10 Ontology Gas Ontology Gas +12.35%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Rangering i aksjer #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Aksjekurs
$12.94
Sist synkronisert: 2026-08-28
Markedsverdi
$1.10B
Endring (1 dag)
-0.16%
Endring (1 år)
-51.50%
Land
US
Handel Kolon TissueGene, Inc. (950160)

Kategori

Healthcare
EPS for Kolon TissueGene, Inc. (950160)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Kolon TissueGene, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Kolon TissueGene, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH